Lijuan Deng

Featured in: Favicon

medsci.org Favicon

giejournal.org Favicon

onlinelibrary.wiley.com

Articles

Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open‐label study

Aug 31, 2023 | onlinelibrary.wiley.com | Lijuan Deng |Zhiming Li |Huilai Zhang |Haiwen Huang

CONFLICT OF INTEREST STATEMENT The authors declare that they have no conflict of interest. Supporting Information Filename Description ajh27064-sup-0001-Supinfo.docWord document, 435.2 KB Data S1: Supplementary Information. REFERENCES 1, , , , , . Epidemiology of non-Hodgkin's lymphoma. Med Sci (Basel). 2021; 9(1): 5. doi:10.3390/medsci9010005 2, . Epidemiology of marginal zone lymphoma. Ann Lymphoma. 2021; 5: 1. doi:10.21037/aol-20-28 3, .

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →